Aprea Therapeutics AB

Aprea Therapeutics AB

Description

Aprea Therapeutics is a clinical stage, platform biotechnolog focused on the development of novel company targeting the ATR pathway (ataxia telangiectasia and Rad3-related) to limit the ability of tumor cells.

Aprea Therapeutics AB

Address

Nobels väg 16, 171 65 Solna, Sweden
Solna, Sweden

Contact

info@aprea.com

Description

Aprea Therapeutics is a clinical stage, platform biotechnolog focused on the development of novel company targeting the ATR pathway (ataxia telangiectasia and Rad3-related) to limit the ability of tumor cells.

Matchmaking

Connect with Aprea Therapeutics AB

This entity is yours?

Update information

Position on the value chain

With the ultimate aim to create a European alliance for bioproduction in Europe, organisations have joined forces with COBIOE. Discover who are our associates.

Bio-resources and biobanking
  • Cells, tissues and humanized xeno-organs
  • Biosamples
  • Viral, phage or bacterial specimen
Identification of biotherapies
  • Target identification
  • Target validation
  • Screening
Drug design
  • Drug assessment
  • Drug engineering
  • In vitro preclinical studies
Clinical validation
  • Clinical trials
  • In vivo preclinical validation
  • Pre-industrial scale production
Production
  • Upstream processes
  • Downstream processes
  • Quality control
Market access
  • CE mark / market authorisation
  • Payment / Reimbursement
  • Care pathways